Indian Pharmacopoeia 2026 highlights need for stronger drug standards and global alignment
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
The company allocated €56 million to research and development for next-generation line solutions
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
The national platform brought together healthcare professionals, patient advocates, and stakeholders
Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Subscribe To Our Newsletter & Stay Updated